Investors Overview

 

Nuvo is focused on increasing shareholder value by:

  • Committing to disciplined spending
  • Building a leader in the topical pain space
  • Focusing on growing revenues organically and through acquisition
  • Optimizing the value of the pain and immunology pipelines
 

Stock
Symbol		 Shares Outstanding Latest
News		 Financial
Information		 Investor
Presentation
TMX - NRI 565 million 2012 2010 Annual Report January 2012

 

 

 

Investor relations inquiries or requests for a Nuvo investor package - please email: ir@nuvoresearch.com